Breaking News

  • 2 days ago

  • Simantini Singh Deo

Novartis Wins FDA Approval For Pluvicto In Earlier Stage Metastatic Prostate Cancer, Expanding Patient Access
Breaking News

More News

XORTX Therapeutics Appoints Financial Services Veteran Depesh Narotam As Independent Director

XORTX Therapeutics Appoints Financial Services Veteran Depesh Narotam ...

Simantini Singh Deo

Ad
Advertisement

Interviews & Opinions

Article

CAR-T therapies can cure blood cancers. They cost $400k-$500k per patient. Ms. Archana Ganesh on why manufacturing — not science — is the last wall st...

FT - Ms. Archana Ganesh, M.S.

Read More

Article
Quality, Leadership, and the Future of Indian Pharma: 38 Years of Wisdom from Dr Rajiv Desai

FT - Dr Rajiv Desai

Ad
Advertisement
Ad